抗凝治疗对肾病综合征的临床疗效观察  

Clinical Efficiency of Anti-coagulative Agents in Treatment of Nephrotic Syndrome

作　　者：冯明利[1] 王艳丽[1] 

机构地区：[1]南京铁道医学院附院肾脏病科,210009

出　　处：《铁道医学》1992年第3期144-145,共2页Railway Medical Journal

摘　　要：应用血栓弹力图、血小板聚集和血小板粘附功能指标,对26例抗凝治疗的肾病综合征患者进行了临床疗效观察。结果治疗组与对照组相比差异有显著意义(P<0.05～0.01)。提示肝素、低分子右旋糖酐和丹参对肾病综合征明具有明显的临床疗效。Clinical efficiency of anti-coagulativc treatment of 26 patients with nephrotic syndrome was studied using TEG and the parameters of PAGT and PAdT.Significant differences were found between the treatment group and the control group(P<0.05～0.01).It suggests a rnarked clinical efficiency of heparin, dextran-40 and Saliva Miltiorrhiza Bunge in treatment of nephrotic syndrome.

关 键 词：肾病综合征 抗凝疗法 疗效 

分 类 号：R692.05[医药卫生—泌尿科学]